CDKN3 Antikörper
Kurzübersicht für CDKN3 Antikörper (ABIN2718436)
Target
Alle CDKN3 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Produktmerkmale
- Homo sapiens cyclin-dependent kinase inhibitor 3 (CDKN3), transcript variant 1
-
Aufreinigung
- Purified from mouse ascites fluids by affinity chromatography
-
Immunogen
- Full length human recombinant protein of human CDKN3(NP_005183) produced in HEK293T cell.
-
Isotyp
- IgG2a
-
-
-
-
Applikationshinweise
- WB 1:500, IHC 1:150, FLOW 1:100,
-
Kommentare
-
The concentration of the product may vary between diferrent lots.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.5-1.0 mg/mL
-
Buffer
- PBS (PH 7.3) containing 1 % BSA, 50 % glycerol and 0.02 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
-
- CDKN3 (Cyclin-Dependent Kinase Inhibitor 3 (CDKN3))
-
Andere Bezeichnung
- CDKN3
-
Hintergrund
- The protein encoded by this gene belongs to the dual specificity protein phosphatase family. It was identified as a cyclin-dependent kinase inhibitor, and has been shown to interact with, and dephosphorylate CDK2 kinase, thus prevent the activation of CDK2 kinase. This gene was reported to be deleted, mutated, or overexpressed in several kinds of cancers. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.
-
Molekulargewicht
- 23.6 kDa
-
Gen-ID
- 1033
-
NCBI Accession
- NM_005192
-
HGNC
- 1033
Target
-